资讯
2 小时
The Kathmandu Post on MSNCipla launches AI initiative to support respiratory patients in NepalCipla Limited, a global pharmaceutical company, has launched an artificial intelligence-powered initiative called ...
TIRUCHY: For 8-year-old Gowtham of Marsingpet, even a mild cough can make it a breathless night. Though doctors have ...
Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...
A recent bronchoscopy, lung infection, and course of antibiotics left columnist Sam Kirton feeling exhausted and frustrated.
Phase 1 Clinical Trials Among the Company’s Five Poster Presentations 4.5 Year Long-Term Safety and Efficacy Data Supporting ...
Wheezing, coughing, tired? You could be missing the silent asthma diagnosis. Doctor reveals signs to watch out for and ...
Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dualinhibitor of PDE3 and PDE4 for a broad COPD ...
While genetics can increase a person's likelihood of developing asthma, high pollution and exposure to harmful environmental ...
The company is presenting data related to its medications designed to advance the prevention and treatment of asthma and COPD.
Lucknow: Improper inhaler use, irregular medication and lack of expert consultation are major reasons why many asthma patients fail to control their c.
The single-inhaler demonstrated a meaningful improvement in lung function in the Phase III KALOS and LOGOS studies.
Inhaled corticosteroids use is common in bronchiectasis, even among patients who don’t meet guideline criteria for ICS use.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果